OECD. Economic, environmental and social statistics. Paris: OECD; 2009.
Barnett K, Mercer SW, Norbury M. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.
Fortin M, Stewart M, Poitras M. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–51.
Neuman P, Cubanski J, Damico A. Medicare per capita spending by age and service: new data highlights oldest beneficiaries. Health Aff. 2014;34:335–9.
Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition-multimorbidity. JAMA. 2012;307:2493–4.
Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol. 2007;4:643–56.
Barbera L, Seow H, Sutradhar R, Chu A, Burge F, Fassbender K, et al. Quality indicators of end-of-life care in patients with cancer: What rate is right? J Oncol Pract. 2015;11(3):e279–87.
Langton JM, Blanch B, Drew AK. Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: a systematic review. Palliat Med. 2014;28:1167–96.
Luta X, Maessen M, Egger M. A., S. Measuring intensity of end of life care: review. PLoS One. 2015;10:e0123764.
Burge FI, Lawson BJ, Johnston GM. A population-based study of age inequalities in access to palliative care among cancer patients. Med Care. 2008;46(12):1203–11.
Gagnon B, Mayo NE, Hanley J. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22(17):3458–65.
Ho TH, Barbera L, Saskin R. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada Oncol. J Clin Oncol 2011, 29:1587-1591.
Setoguchi S, Earle CC, Glynn R. Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol. 2008;26:5671–8.
Shugarman LR, Bird CE, Schuster CR. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. J Women’s Health. 2007;16:214–27.
Shugarman LR, Bird CE, Schuster CR. Age and gender differences in medicare expenditures and service utilization at the end of life for lung cancer decedents. Womens Heal Issues. 2008;18:199–209.
Virnig BA, McBean A, Kind S. Marshall hospice use before death: variability across cancer diagnoses. Med Care. 2002;40:73–8.
Kaul P, McAlister FA, Ezekowitz JA. Resource use in the last 6 months of life among patients with heart failure in Canada. Arch Intern Med. 2011;171:211–7.
Unroe KT, Greiner MA, Hernandez AF. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2006-2007. Arch Intern Med. 2011;171:196–203.
Australian Institute of Health and Welfare (AIHW). Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra: AIHW; 2013.
Australian Institute of Health and Welfare (AIHW). Cancer in Australia: an overview. Canberra: AIHW; 2014.
Lunney JR, Lynn J, Hogan C. Profiles of older medicare decedents. J Am Geriatr Soc. 2002;50:1108–12.
Langton JM, Srasuebkul P, Reeve R, Parkinson B, Gu Y, Buckley NA, et al. Resource use, costs and quality of end of life care: observations in a cohort of elderly Australian cancer decedents. Implement Sci. 2015;10:25.
Centre for Health Record Linkage (CHeReL). http://www.cherel.org.au/.
Reeve R, Haas M. Estimating the cost of emergency department presentations in NSW. CHERE working paper 2014/01. In. Sydney: CHERE; 2014.
Jones A. Models for health care. HEDG working paper 10/01. York: University of York; 2010.
Sundararajan V, Henderson T, Perry C. New ICD 10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004, 57 SRC - GoogleScholar:1288–1294.
Sloan KL, Sales AE, Liu C. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41:761–74.
Lu CY, Barratt J, Vitry A. Charlson and Rx-risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011;64:223–8.
Goldsbury DE, Connell DL, Girgis A, C. BM. O’ Acute hospital-based services used by adults during the last year of life in New South Wales, Australia: a population-based retrospective cohort study. Health Serv Res. 2015; 15:537.
Earle CC, Neville BA, Landrum MB. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17:505–9.
Mack JW, Cronin A, Taback N. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012;156:204–10.
You JJ, Dodek P, Lamontagne F. What really matters in end-of-life discussions? Perspectives of patients in hospital with serious illness and their families. Can Med Assoc J. 2014;186:E679–87.
Burt J, Plant H, Omar R, Raine R. Equity of use of specialist palliative care by age: cross-sectional study of lung cancer patients. Palliat Med. 2010;24(6):641–50.
Burt J, Raine R. The effect of age on referral to and use of specialist palliative care services in adult cancer patients: a systematic review. Age Ageing. 2006;35(5):469–76.
Gardiner C, Cobb M, Gott M, Ingleton C. Barriers to providing palliative care for older people in acute hospitals. Age Ageing. 2011;40(2):233–8.
Australian Institute of Health and Welfare (AIHW). Palliative care services in Australia. Canberra: AIHW; 2014.
The National Palliative Care Strategy 2010. Supporting Australians to live well at the end of life. Canbera: Commonwealth of Australia; 2010.
Gomes B, Calanzani N, Gysels M, C BM. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care. 2013; 12:7.
Gomes B, Higginson IJ, Calanzani N. Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. Ann Oncol. 2012;23:2006–15.
Zhang B, Wright AA, Huskamp HA. Health care costs in the last week of life associations with end-of-life conversations. Arch Intern Med. 2009;169:480–8.
Abernethy AP, Currow DC, Shelby-James T, Rowett D, May F, Samsa GP, et al. Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the “palliative care trial” [ISRCTN 81117481]. J Pain Symptom Manag. 2013;45(3):488–505.
Almaawiy U, Pond GR, Sussman J. Are family physician visits and continuity of care associated with acute care use at end-of-life? A population-based cohort study of homecare cancer patients. Palliat Med. 2014;28:176–83.
McCaffrey N, Cassel JB, Coast J. Bringing the economic cost of informal caregiving into focus. Palliat Med. 2015;29:866–7.
Australian Institute of Health and Welfare (AIHW). Health care usage and costs: A comparison of veterans and war widows and widowers with the rest of the community Canberra Australia. Canberra: AIHW; 2002.
Tooth LR, Hockey R, Treloar S. Does government subsidy for costs of medical and pharmaceutical services result in higher service utilization by older widowed women in Australia? BMC Health Serv Res. 2012;12:179.
Rosenwax LK, McNamara BA, Murray K. Hospital and emergency department use in the last year of life: a baseline for future modifications to end-of-life care. Med J Aust. 2011;194:570–3.
Age at death (AIHW). http://www.aihw.gov.au/deaths/age-at-death/. Accessed 19 Mar 2015.
Australian Cancer Incidence and Mortality (ACIM) books. http://www.aihw.gov.au/acim-books/. Accessed 19 Mar 2015.
Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004;292:2765–70.
Pyenson B, Connor S, Fitch K. Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manag. 2004;28:200–10.